Literature DB >> 3360656

High-dose-rate intracavitary irradiation in the treatment of carcinoma of the uterine cervix: early experience with 84 patients.

Y Akine1, H Arimoto, T Ogino, Y Kajiura, I Tsukiyama, S Egawa, T Yamada, K Tanemura, R Tsunematsu, K Ohmi.   

Abstract

Eighty-four patients with previously untreated invasive carcinoma of the uterine cervix were treated by high-dose-rate intracavitary irradiation using a remotely controlled afterloading system (Ralstron) with or without external irradiation at the National Cancer Center Hospital, Tokyo, between 1977 and 1981. Survival rates and local control rates were comparable to those for 372 patients treated by low-dose-rate intracavitary irradiation with or without external irradiation from 1972 to 1981 at the hospital. The incidence of major complications was 5.1 and 2.4% for the patients treated by low-dose-rate intracavitary irradiation and by high-dose-rate irradiation, respectively. The results are comparable to those reported by other institutions. We have abandoned the conventional low-dose-rate intracavitary irradiation with the impression that the high-dose-rate remotely controlled afterloading system is a good alternative to the conventional one.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360656     DOI: 10.1016/0360-3016(88)90011-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Use of a remote controlled radiotherapy afterloading system to manage unresectable, metastatic thyroid cancer in the trachea.

Authors:  T Nakashima; G Yano; Y Nomura; K Tomita; S Wada; K Hata
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

2.  High versus low-dose rate brachytherapy for cervical cancer.

Authors:  Sonali S Patankar; Ana I Tergas; Israel Deutsch; William M Burke; June Y Hou; Cande V Ananth; Yongmei Huang; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2015-01-06       Impact factor: 5.482

3.  Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation.

Authors:  Aba Anoa Scott; Joel Yarney; Verna Vanderpuye; Charles Akoto Aidoo; Mervin Agyeman; Samuel Ntiamoah Boateng; Evans Sasu; Kwabena Anarfi; Tony Obeng-Mensah
Journal:  Int J Gynecol Cancer       Date:  2021-02-08       Impact factor: 3.437

4.  Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy - a meta-analysis of clinical trials.

Authors:  Gustavo A Viani; Gustavo B Manta; Eduardo J Stefano; Ligia I de Fendi
Journal:  J Exp Clin Cancer Res       Date:  2009-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.